- Home
- OABI vs LPRO Comparison
OABI vs LPRO Comparison
Compare OABI & LPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- LPRO
- Stock Information
- Founded
- OABI 2012
- LPRO 2000
- Country
- OABI United States
- LPRO United States
- Employees
- OABI N/A
- LPRO N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- LPRO Finance: Consumer Services
- Sector
- OABI Health Care
- LPRO Finance
- Exchange
- OABI Nasdaq
- LPRO Nasdaq
- Market Cap
- OABI 239.0M
- LPRO 252.9M
- IPO Year
- OABI N/A
- LPRO N/A
- Fundamental
- Price
- OABI $1.58
- LPRO $1.70
- Analyst Decision
- OABI Strong Buy
- LPRO Buy
- Analyst Count
- OABI 3
- LPRO 6
- Target Price
- OABI $6.67
- LPRO $3.00
- AVG Volume (30 Days)
- OABI 544.6K
- LPRO 788.1K
- Earning Date
- OABI 11-04-2025
- LPRO 11-06-2025
- Dividend Yield
- OABI N/A
- LPRO N/A
- EPS Growth
- OABI N/A
- LPRO N/A
- EPS
- OABI N/A
- LPRO N/A
- Revenue
- OABI $21,094,000.00
- LPRO $16,948,000.00
- Revenue This Year
- OABI N/A
- LPRO $306.78
- Revenue Next Year
- OABI $48.89
- LPRO $11.69
- P/E Ratio
- OABI N/A
- LPRO N/A
- Revenue Growth
- OABI 3.36
- LPRO N/A
- 52 Week Low
- OABI $1.22
- LPRO $0.70
- 52 Week High
- OABI $4.61
- LPRO $6.80
- Technical
- Relative Strength Index (RSI)
- OABI 49.87
- LPRO 44.59
- Support Level
- OABI $1.33
- LPRO $1.35
- Resistance Level
- OABI $1.64
- LPRO $2.01
- Average True Range (ATR)
- OABI 0.09
- LPRO 0.14
- MACD
- OABI 0.01
- LPRO -0.00
- Stochastic Oscillator
- OABI 55.92
- LPRO 52.67
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About LPRO Open Lending Corporation
Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against, losses from defaults.